U.S. flag

An official website of the United States government

GTR Home > Conditions/Phenotypes > Hypogonadotropic hypogonadism 7 with or without anosmia

Hypogonadotropic hypogonadism 7 with or without anosmia

Synonyms
HYPOGONADOTROPIC HYPOGONADISM 7 WITHOUT ANOSMIA; Isolated Gonadotropin-Releasing Hormone (GnRH) Deficiency

Summary

Excerpted from the GeneReview: Isolated Gonadotropin-Releasing Hormone (GnRH) Deficiency
Isolated gonadotropin-releasing hormone (GnRH) deficiency (IGD) is characterized by inappropriately low serum concentrations of the gonadotropins LH (luteinizing hormone) and FSH (follicle-stimulating hormone) in the presence of low circulating concentrations of sex steroids. IGD is associated with a normal sense of smell (normosmic IGD) in approximately 40% of affected individuals and an impaired sense of smell (Kallmann syndrome) in approximately 60%. IGD can first become apparent in infancy, adolescence, or adulthood. Infant boys with congenital IGD often have micropenis and cryptorchidism. Adolescents and adults with IGD have clinical evidence of hypogonadism and incomplete sexual maturation on physical examination. Adult males with IGD tend to have prepubertal testicular volume (i.e., <4 mL), absence of secondary sexual features (e.g., facial and axillary hair growth, deepening of the voice), decreased muscle mass, diminished libido, erectile dysfunction, and infertility. Adult females have little or no breast development and primary amenorrhea. Although skeletal maturation is delayed, the rate of linear growth is usually normal except for the absence of a distinct pubertal growth spurt.
Full text of GeneReview (by section):
Summary
GeneReview Scope
Diagnosis
Clinical Characteristics
Genetically Related (Allelic) Disorders
Differential Diagnosis
Management
Genetic Counseling
Resources
Molecular Genetics
Chapter Notes
References
Authors:
Ravikumar Balasubramanian
William F Crowley
view full author information

Available tests

54 tests are in the database for this condition.

Clinical tests (52 available)

Molecular Genetics Tests

Research tests

Genes See tests for all associated and related genes

  • Also known as: ARK, AXL3, JTK11, Tyro7, UFO, AXL
    Summary: AXL receptor tyrosine kinase

  • Also known as: CAMDI, CCDC141
    Summary: coiled-coil domain containing 141

  • Also known as: HH19, MKP3, PYST1, DUSP6
    Summary: dual specificity phosphatase 6

  • Also known as: FEZ, HH22, ZNF312B, FEZF1
    Summary: FEZ family zinc finger 1

  • Also known as: FGF-13, FGF-17, HH20, FGF17
    Summary: fibroblast growth factor 17

  • Also known as: GNRH, GRH, LHRH, LNRH, GNRH1
    Summary: gonadotropin releasing hormone 1

  • Also known as: GNRHR1, GRHR, HH7, LHRHR, LRHR, GNRHR
    Summary: gonadotropin releasing hormone receptor

  • Also known as: M-SEMAH, M-SemaK, SEMAH, coll-5, SEMA3E
    Summary: semaphorin 3E

  • Also known as: HH17, SPRY4
    Summary: sprouty RTK signaling antagonist 4

  • Also known as: SRA, SRAP, STRAA1, pp7684, SRA1
    Summary: steroid receptor RNA activator 1

  • Also known as: BRWD2, DR11, HH14, SRI1, WDR15, WDR11
    Summary: WD repeat domain 11

Clinical features

Help
Imported from Human Phenotype Ontology (HPO)

Show allHide all

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.